PSRC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.287200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.759400E-01
Normal-vs-Stage2
4.950800E-01
Normal-vs-Stage3
7.495200E-01
Normal-vs-Stage4
7.147400E-01
Stage1-vs-Stage2
4.345400E-01
Stage1-vs-Stage3
6.777600E-01
Stage1-vs-Stage4
8.719200E-01
Stage2-vs-Stage3
3.087200E-01
Stage2-vs-Stage4
6.225000E-01
Stage3-vs-Stage4
5.573200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.514000E-01
Normal-vs-AfricanAmerican
5.909800E-01
Normal-vs-Asian
1.342220E-01
Caucasian-vs-AfricanAmerican
9.817400E-01
Caucasian-vs-Asian
3.294800E-01
AfricanAmerican-vs-Asian
6.048800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.862800E-01
Normal-vs-Female
3.145700E-02
Male-vs-Female
7.590600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.094600E-01
Normal-vs-Age(41-60Yrs)
1.133550E-02
Normal-vs-Age(61-80Yrs)
5.556000E-01
Normal-vs-Age(81-100Yrs)
3.253200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.795600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.166200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.191970E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.534820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.368200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.231600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.925000E-01
Normal-vs-Daily Drinker
3.386600E-01
Normal-vs-Weekly Drinker
2.073200E-01
Normal-vs-Occasional Drinker
2.746600E-01
Normal-vs-Social Drinker
4.685200E-01
Non Drinker-vs-Daily Drinker
3.352800E-01
Non Drinker-vs-Weekly Drinker
3.794600E-01
Non Drinker-vs-Occasional Drinker
5.803600E-01
Non Drinker-vs-Social Drinker
6.664000E-01
Daily Drinker-vs-Weekly Drinker
5.893000E-01
Daily Drinker-vs-Occasional Drinker
6.546400E-01
Daily Drinker-vs-Social Drinker
6.900600E-01
Weekly Drinker-vs-Occasional Drinker
4.811600E-01
Weekly Drinker-vs-Social Drinker
4.866800E-01
Occasional Drinker-vs-Social Drinker
9.730400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.625800E-01
Normal-vs-Grade 2
6.087800E-01
Normal-vs-Grade 3
6.093200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.08050000002802E-06
Grade 1-vs-Grade 3
1.217650E-04
Grade 1-vs-Grade 4
5.625800E-01
Grade 2-vs-Grade 3
9.656800E-01
Grade 2-vs-Grade 4
6.087800E-01
Grade 3-vs-Grade 4
6.093200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.477200E-01
Normal-vs-NonDiabetic
8.877800E-03
Diabetic-vs-NonDiabetic
5.792200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.378750E-01
Normal-vs-NoPancreatitis
2.836000E-02
Pancreatitis-vs-NoPancreatitis
2.908800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.328800E-01
Normal-vs-N1
2.146200E-02
N0-vs-N1
7.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.168400E-04
Normal-vs-TP53-NonMutant
6.133400E-01
TP53-Mutant-vs-TP53-NonMutant
2.220000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
